Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: A 3-year follow-up study

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 8, 2007, Pages 1217-1220

  Choontanom, Raveewan ^a,b   Thanos, Solon ^a   Busse, Holger ^a   Stupp, Tobias ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b PHRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

Basal cell carcinoma; Eyelid; Immunomodulatory drug therapy

Indexed keywords

IMIQUIMOD;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONJUNCTIVITIS; CREAM; DRUG EFFICACY; DRUG SAFETY; EYELID CARCINOMA; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; SKIN MANIFESTATION; SYMPTOM;

ADMINISTRATION, TOPICAL; ADULT; AGED; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; EYELID NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OINTMENTS; TREATMENT OUTCOME;

EID: 34447122462     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0561-1     Document Type: Article

References (7)

1. Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M (2004) Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 50:722733
2. Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrandiz C, Garcia Diez A, Tebbs V, McRae S (2005) Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 152:939-947
3. Huber A, Huber JD, Skinner RB Jr, Kuwahara RT, Haque R, Amonette RA (2004) Topical imiquimod treatment for nodular basal cell carcinomas: An open-label series. Dermatol Surg 30:429-430
4. Shumack S, Robinson J, Kossard S, Golitz L, Greenway H, Schroeter A, Andres K, Amies M, Owens M (2002) Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens. Arch Dermatol 138:1165-1171
5. Blasi MA, Giammaria D, Balestrazzi E (2005) Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma. Am J Ophthalmol 140:1136-1139
6. Sauder DN (2004) Mechanism of action and emerging role of immune response modifier therapy in dermatologic conditions. J Cutan Med Surg 8[Suppl 3]:3-12
7. Urosevic M, Maier T, Benninghoff B, Slade H, Burg G, Dummer R (2003) Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol 139:1325-1332